Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

March 03, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people ...

A research team at the University of Illinois says it's developed a bioprinted cardiac tissue that can be remotely stimulated ...

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.

Raythera Inc. has identified TNF-α modulators reported to be useful for the treatment of inflammatory disorders, autoimmune disease, neurological disorders, pain, cardiovascular disorders, cancer, ...

The peptide is primarily studied for its potential to influence pigmentation Melanotan-2 (MT-2), a synthetic peptide derived ...

The American Society of Pain and Neuroscience (ASPN) has just issued UPDATED guidelines for physicians using neuromodulation ...

Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch– First ...

Topline data readouts from multiple Phase 2 studies expected throughout 2025VTX2735 in patients with recurrent pericarditis in H2VTX3232 in ...

Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch - First of three planned Phase 3 azetukalner MDD studies underwa ...

by the Wyss Center for Bio and Neuro-engineering and by the Swiss National Competence Center in Research (NCCR) in Robotics. Competing interests SM, SR, FMP hold shares of Sensars Neuroprosthetics, a ...